From: A systematic review of community based hepatitis C treatment
Study | Facility | N | Age (years) | Gender (% male) | Genotype 1 (%) | HIV infected n (%) | Prior treatment | Fibrosis assessment | Fibrosis result | SVR |
---|---|---|---|---|---|---|---|---|---|---|
Mean or % | n (%) | |||||||||
Arora | Tertiary | 146 | 45 | 45 | 57 | 0 | Naive | APRI | 0.938 | 84 (58) |
Telehealth | 261 | 42 | 73 | 56 | 0 | 0.935 | 152 (58) | |||
Bruce | Tertiary | 9 | 43 | 67 | 67 (G1&4) | 3 (33) | N/P | Biopsy (G1 only) | F4 33 % | 1 (33) |
Primary | 12 | 40 | 42 | 67 (G1&4) | 3 (25) | F4 25 % | 6 (75) | |||
Chen | Tertiary | 150 | 52 | N/P | 58 | 0 | Naive | N/P | 99 (66) | |
Primary | 148 | 47 | N/P | 61 | 0 | N/P | 102 (69) | |||
Jou | Academic | 1905 | 48 | 59 | 100 | 0 | Naive | Biopsy | F3/4 10 % | 760 (40) |
Community | 1165 | 47 | 61 | 100 | 0 | F3/4 11 % | 455 (39) | |||
Kuo | Preintervention | 18 | 57 | 33 | N/P | N/P | N/P | N/P | 2 (50) | |
Post intervention | 3 (100) | |||||||||
Myers | Academic | 133 | 46 | 70 | 49 | 0 | Naïve & experienced | Biopsy | F4 14 % | 79 (59) |
Community | 250 | 46 | 64 | 55 | 0 | F4 10 % | 120 (48) | |||
Nazareth | Tertiary | 528 | 43 | 65 | N/P | N/P | Naïve & experienced | Biopsy or Hepascore | F4 19 % | 311 (59) |
Telehealth | 50 | 46 | 50 | 60 | N/P | Hepascore | F4 20 % | 36 (72) | ||
Niedaerau | Hospital based | 621 | N/P | N/P | 100 | N/P | N/P | N/P | 290 (47) | |
Private practice | 3778 | N/P | N/P | 100 | N/P | N/P | 1744 (46) | |||
Rossaro | Tertiary | 40 | 54 | 55 | 65 | 0 | Naive | Biopsy | F4 45 % | 16 (43) |
Telehealth | 40 | 51 | 48 | 65 | 0 | F4 28 % | 21 (55) |